1993
DOI: 10.1006/clin.1993.1123
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Cytomegalovirus DNA and Protein Expression in Patients with Myocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
2
2

Year Published

1996
1996
2002
2002

Publication Types

Select...
5
4

Relationship

4
5

Authors

Journals

citations
Cited by 33 publications
(17 citation statements)
references
References 0 publications
0
12
2
2
Order By: Relevance
“…Our protocol has been previously published (8,10,12). In brief, after deparaffinization, sections were incubated with CD45 or CD68 (DAKO, Carpinteria, CA).…”
Section: Immunohistochemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…Our protocol has been previously published (8,10,12). In brief, after deparaffinization, sections were incubated with CD45 or CD68 (DAKO, Carpinteria, CA).…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…In cases of sudden, unexpected death, serology is usually not available, and viral cultures have relatively low sensitivity, especially in the autopsy setting (8). In situ hybridization analyses for DNA viruses, which are associated with high copy number, show both high sensitivity and specificity, as documented in cases of cytomegalovirus and adenovirus-associated myocarditis (12)(13)(14). However, most cases of viral myocarditis are associated with RNA viruses, in which the viral genome number may be below the detection threshold of the assay, which is about 10 copies per cell (15)(16)(17).…”
mentioning
confidence: 99%
“…Primer pairs specific for the following gene segment were used for amplification and/or reverse transcription [2,4,9,11,23,26,27]:…”
Section: Molecular Biological Analysesmentioning
confidence: 99%
“…Dilated Cardiomyopathy The prevalence of cytomegaloviral DNA in endomyocardial biopsies from patients with myocarditis by PCR or nested PCR ranged from 3% (low) in the analyses by Martin et al [24] and Towbin et al [40] to 38% (high) in the analyses by Schönian et al [37]. In patients with dilated cardiomyopathy the prevalence of cytomegaloviral genome ranged from 0% (low) in the analyses by Towbin et al [40] to 40% (high) in the analyses by Schönian et al [37].…”
Section: Cytomegaloviral Persistence In Myocarditis Andmentioning
confidence: 99%